Snowball logo
logo
OTLK_logo

Outlook Therapeutics Inc

OTLK β€’ NASDAQ
$0.5293+$0.016Β  (3.12%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
---0.1701241.413535(1.163181)
COGS
0.2621390.2046940.04420.1138590.756331.112468
Gross Profit
(0.262139)(0.204694)(0.0442)(0.113859)0.657205(2.275649)
Operating Expenses & Income
Operating Income
(51.73)(63.07)(53.13)(71.7)(67.06)(55.64)
Total Operating Expenses
51.7362.8753.1371.767.7253.36
R&D Expenses
38.9642.3326.4541.7627.7817.36
Selling General & Admin Expenses
12.7720.7426.6729.9439.9436
Earnings from Continuing Operations
Interest Expense
(0.936127)(1.487)(2.531228)(3.156964)(0.283128)(3.264156)
Interest Income
--0.971480.906150.0897-
Income Tax Expense
0.0020.00280.00280.0028(1.551829)(1.513629)
Net Income
Net Income
(53.16)(66.05)(58.98)(75.37)(62.42)(61.12)
Supplemental
EBIT
(52.23)(64.56)(56.45)(72.21)(63.69)(62.31)
EBITDA
(51.96)(64.36)(56.4)(72.09)(63.58)(62.28)
In millions of USD, except % and values per 1 share